...
首页> 外文期刊>BMC Ophthalmology >Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration
【24h】

Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration

机译:半血液中小型光动力治疗后血管内流体的瞬态积聚在新生血管时代相关性黄斑变性中

获取原文
           

摘要

Photodynamic therapy (PDT) is known to occlude choroidal neovascularisation selectively, and there have been several reports on its adverse effects on the normal choroid and retinal pigment epithelium, resulting in decreased vision. This retrospective interventional case series aimed to investigate the changes in visual acuity and retinal thickness in the immediate post-treatment period after half-fluence PDT, administered alone or with anti-vascular endothelial growth factor and steroids, in 29 eyes (26 patients) with neovascular age-related macular degeneration. The patients’ best-corrected visual acuity (BCVA) and central foveal thickness (CFT) on optical coherence tomography images were measured 1?day, 1?week, and 1?month post-treatment. Compared to the pre-treatment CFT (270.38?μm), the mean CFT was significantly increased 1?day post-treatment (387.07?μm, P?=?0.001), which then started to decrease, with a mean CFT of 269.32?μm (P?=?0.516) at 1?week, and of 240.66?μm (P?=?0.066) at 1?month post-treatment. All CFT increases were due to the accumulation of subretinal fluid (SRF), rather than the intraretinal or subretinal pigment epithelium fluid. Relative to the pre-treatment BCVA (0.59 logMAR), the mean BCVA at 1?day (0.74 logMAR, P?=?0.005) and 1?week (0.75 logMAR, P?=?0.002) post-treatment was significantly deteriorated; however, it recovered to 0.62 logMAR at 1?month. The patterns of change in CFT and BCVA did not differ according to treatment modality. Half-fluence PDT resulted in accumulation of SRF in the immediate post-treatment period; this damage mostly recovered within a week, and the BCVA was restored within a month.
机译:已知光动力疗法(PDT)可选择地闭塞脉络膜新生血管,并且有几个关于其对正常脉络膜和视网膜色素上皮的不良影响的报告,导致视力下降。这种回顾性的介入案例系列旨在调查半流量PDT后立即治疗后的视力和视网膜厚度的变化,单独或用抗血管内皮生长因子和类固醇,29只眼(26名患者)新生血管年龄相关的黄斑变性。测量患者的最佳矫正视力(BCVA)和中央芯片厚度(BCVA)和中央芯片厚度(CFT)测量1?天,1个?周,1?月后处理。与预处理的CFT(270.38Ωμm)相比,平均CFT显着增加1?天后1-天(387.07≤μm,p?= 0.001),然后开始减少,平均CFT为269.32? μm(p?= 0.516),在1?周,240.66?μm(p?= 0.066),在治疗后1个月。所有CFT增加都是由于分子液(SRF)的积累,而不是体内或子序列颜料上皮液。相对于预处理BCVA(0.59 Logmar),平均BCVA在1?日(0.74 logmar,p?= 0.005)和1?周(0.75 logmar,p?= 0.002)后治疗显着恶化;但是,它恢复到0.62 logmar,在1?月份。 CFT和BCVA的变化模式没有根据治疗方式而不同。半流量PDT导致立即治疗期间累积SRF;这种伤害主要在一周内恢复,BCVA在一个月内恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号